Emmaus Life Sciences, Inc. (EMMA) stock
EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
$0.05−0.01 (-14.38%)
Close on Oct 19, 2026Market cap $6.03MP/E –Yield –
Emmaus Life Sciences EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Emmaus Life Sciences's EV/EBITDA was 0.2× on Oct 19, 2026, against 40.3× a year earlier.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 0.2× | −15.8 |
| 2024 | Nov 29, 2024 | 16.0× | +11.2 |
| 2023 | Dec 29, 2023 | 4.8× | – |
See a number that looks wrong?